Mar 11 2012
Med Mal comes in the form of a drug March 6th
Shire is taking aim at Johnson & Johnson’s ($JNJ) Concerta. The Irish drugmaker is sponsoring two head-to-head trials pitting its ADHD drug Vyvanse against the J&J product as a treatment for adolescents with the disorder. But it’s not just J&J’s branded product in Shire’s sights. Generic versions of Concerta are already on the market, and […]
Comments Off on Med Mal comes in the form of a drug March 6th
